Induction of hepatic cytochromes P450 by dietary 1,4-bis[2-(3,5- dichloropyridyloxy)]benzene (TCPOBOP) in the B6C3F1 mouse: Dose-dependence and pharmacodynamics

International Journal of Toxicology

Volumn 18, Issue 2, 1999, Pages 123-130

  Nims, R W ^a,e   Beebe, L E ^a   Utermahlen Jr , W E ^b   Thomas, P E ^c   Lubet, R A ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e BioReliance Corporation   (United States)

Author keywords

B6C3F1 Mice; Cytochrome(s) P450 Induction; Pharmacodynamics; TCPOBOP

Indexed keywords

1,4 BIS(3,5 DICHLORO 2 PYRIDYLOXY)BENZENE; CARCINOGEN; CYTOCHROME P450; PHENOBARBITAL; RESORUFIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CATALYSIS; CONTROLLED STUDY; DEALKYLATION; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INDUCTION; LIVER TUMOR; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PHARMACODYNAMICS; WESTERN BLOTTING;

EID: 0032986331     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/109158199225693     Document Type: Article

References (29)

1. Beebe, L., S. S. Park, and L. M. Anderson. 1990. Differential enzyme induction of mouse liver and lung following a single low or high dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J. Biochem. Toxicol. 5:211-219.
2. Böhlen, P., S. Stein, W. Dairman, and S. Udenfriend. 1973. Fluorometric assay of proteins in the nanogram range. Arch. Biochem. Biophys. 155:213-220.
3. Burke, M. D., S. Thompson, C. R. Elcombe, J. Halpert, T. Haaparanta, and R. T. Mayer. 1985. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 34:3337-3345.
4. Diwan, B. A., J. R. Henneman, J. M. Rice, and R. W. Nims. 1996. Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B. Carcinogenesis 17:37-43.
5. Diwan, B. A., R. A. Lubet, J. M. Ward, J. A. Hrabie, and J. M. Rice. 1992. Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with N-nitrosodiethylamine. Carcinogenesis 13:1893-1901.
6. Gourley, D. R. H. 1971. Interactions of drugs with cells, 35-41. Springfield, IL: C. C. Thomas.
7. Holford, N. H. G., and L. B. Sheiner. 1981. Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin. Pharmacokinet. 6:429-453.
8. Honkakoski, P., S. Auriola, and M. A. Lang. 1992. Distinct induction profiles of three phenobarbital-responsive mouse liver cytochrome P450 isozymes. Biochem. Pharmacol. 43:2121-2128.
9. Honkakoski, P., R. Moore, J. Gynther, and M. Negishi. 1996. Characterization of phenobarbital-inducible mouse CYP2bI0 gene transcription in primary hepatocytes. J. Biol. Chem. 271:9746-9753.
10. Jones C. R., R. A. Lubet, J. R. Henneman, and R. W. Nims. 1998. Dose-response relationships for cytochrome P450 induction by phenobarbital in the cotton rat (Sigmodon hispidus). Comp. Biochem. Physiol. 121:197-203.
11. Kelley, M., I. Lambert, J. Merrill, and S. Safe. 1985. 1,4-Bis[2-(3.5-dichloropyridyloxy)]benzene (TCPOBOP) and related compounds as inducers of hepatic monooxygenases. Structure-activity effects. Biochem. Pharmacol. 34:3489-3494.
12. Kende, A. S., F. H. Ebetino, W. B. Drendel, M. Sundaralingam, E. Glover, and A. Poland. 1985. Structure-activity relationship of bispyridyloxybenzene for induction of mouse hepatic aminopyrine N-demethylase activity. Mol. Pharmacol. 28:445-453.
13. Lubet, R. A., R. T. Mayer, J. W. Cameron, R. W. Nims, M. D. Burke, T. Wolff, and F. P. Guengerich. 1985a. Dealkylation of pentoxyresorufin: A rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch. Biochem. Biophys. 238:43-48.
14. Lubet, R. A., R. W. Nims, R. T. Mayer, J. W. Cameron, and L. M. Schechtman. 1985b. Measurement of cytochrome P-450 dependent dealkylation of alkoxyphenoxazones in hepatic S9s and hepatocyte homogenates: Effects of dicumarol. Mutat. Res. 142:127-131.
15. Nerurkar, P. V., S. S. Park, P. E. Thomas, R. W. Nims, and R. A. Lubet. 1993. Methoxyresorufin and benzyloxyresorufin: Substrates preferentially metabolized by cytochromes P450 1A2 and 2B, respectively, in the rat and mouse. Biochem. Pharmacol. 46:933-943.
16. NIH. 1985. Guide for the Care and Use of Laboratory Animals. (NIH Publication No. 86-23). Public Health Service. National Institute of Health.
17. Nims, R. W., R. A. Lubet, B. A. Diwan, D. W. Mellini, W. E. Utermahlen Jr., and P. E. Thomas. 1994. Hepatic cytochrome P450 2B induction by ethyl/phenyl-substituted ongeners of phenobarbital in the B6C3F1 mouse. J. Biochem. Toxicol. 9:269-278.
18. Nims, R. W., R. A. Lubet, C. R. Jones, D. W. Mellini, and P. E. Thomas. 1993a. Comparative pharmacodynamics of CYP2B induction by phenobarbital in the male and female F344/NCr rat. Biochem. Pharmacol. 45:521-526.
19. Nims, R. W., P. R. Sinclair, J. F. Sinclair, K. H. Dragney, C. R. Jones, D. W. Mellini, P. E. Thomas, and R. A. Lubet. 1993b. Dose-response relationships for the induction of P450 2B by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in rat and cultured rat hepatocytes. Xenobiotica 23:1411-1426.
20. Nims, R. W., J.-L. Syi, D. A. Wink, V. C. Nelson, P. E. Thomas, C. R. Jones, B. A. Diwan, L. K. Keefer, J. M. Rice, and R. A. Lubet. 1993c. Hepatic cytochrome P450 2B-type induction by ethyl/phenyl-substituted congeners of phenobarbital in the rat. Chem. Res. Toxicol. 6:180-187.
21. Omiecinski, C. J., R. W. Nims, and J. S. Sidhu. 1996. Induction of CYP gene expression by p-hydroxyphenobarbital and p-hydroxyphenytoin in primary rat hepatocytes. Toxicologist 30:70 (abstract 365).
22. Poland, A., I. Mak, and E. Glover. 1981. Species differences in responsiveness to 1,4-bis[2-(3,5-dichloropyridyloxy)]-benzene, a potent phenobarbital-like inducer of microsomal monooxygenase activity. Mol. Pharmacol. 20: 442-450.
23. Poland, A., I. Mak, E. Glover, R. J. Boatman, F. H. Ebetino, and A. S. Kende. 1980. 1,4-Bis[2-(3,5-dichloropyridyloxy)]-benzene, a potent phenobarbital-like inducer of microsomal monooxygenase activity. Mol. Pharmacol. 18:571-580.
24. Qualls, C. W., Jr., R. A. Lubet, R. L. Lochmiller, C. Elangbam, J. W. Lish, and R. W. Nims. 1998. Cytochrome P450 induction in feral Cricetid rodents: A review of field and laboratory investigations. Comp. Biochem. Physiol. 121:55-63.
25. Raunio, H., A. Kojo, R. Juvonen, P. Honkakoski, P. Järvinen, M. A. Lang, K. Vähäkangas, H. V. Gelboin, S.-S. Park, and O. Pelkonen. 1988. Mouse hepatic cytochrome P-450 isozyme induction by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, pyrazole, and phenobarbital. Biochem. Pharmacol. 37:4141-4147.
26. Reik, L. M., W. Levin, D. E. Ryan, S. L. Maines, and P. E. Thomas. 1985. Monoclonal antibodies distinguish among isozymes of the cytochrome P-450b subfamily. Arch. Biochem. Biophys. 242:365-382.
27. Romano, M., A. Esteve, P. Coccia, P. Masturzo, G. Galliani, P. Ghezzi, and M. Salmona. 1986. Biochemical characterization of the hepatic effects in mice and rats of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, a hepatic neoplasm promoter. Toxicol. Appl. Pharmacol. 83:379-385.
28. Schmidt, N. S., P. Carrott, N. L. Leonard, A. Madan, and A. Parkinson. 1996. Investigation of the induction of 7-pentoxyresorufin O-dealkylation (PROD) in mice treated with CYP1A enzyme inducers. Toxicologist 30:76 (abstract 392).
29. Smith, G., C. J. Henderson, M. G. Parker, R. White, R. G. Bars, and C. R. Wolf. 1993. 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, an extremely potent modulator of mouse hepatic cytochrome P-450 gene expression. Biochem. J. 289:807-813.